NetworkNewsBreaks

TuesdayOct 08, 2019 9:26 am

NetworkNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Portfolio Company Receives Health Canada Approval for Facility Expansion

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Monday announced that its portfolio company TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) has gained Health Canada approval for a significant expansion at its Mississauga, Ontario facility. TerrAscend anticipates that the approval will assist in the company’s goal to meet the growing consumer demand for premium cannabis products and brands expected to surge as the next wave of Canadian cannabis legalization. The approval almost triples TerrAscend's licensed space to 51,800 square feet. The new space will be comprised of supplementary cultivation capacity, a commercial kitchen, formulation rooms…

Continue Reading

MondayOct 07, 2019 12:32 pm

NetworkNewsBreaks – Trxade Group Inc. (TRXD) Empowers Small, Independent Pharmacies

Integrated pharmaceutical services company Trxade Group (OTCQB: TRXD) provides pricing analytics for its clients, including smaller, independent pharmacies. An article discussing the company reads, “Through its platform, as well as the upcoming launch of other innovative products, Trxade Group is working hard to empower small, independent pharmacies. The company announced that, due to high demand, it will continue rolling out innovative products in the future. New product offerings have already been developed to offer increased data-analysis capacity and better inventory/cost management. . . . User analytics is one of the primary tools that independent pharmacies can rely on to increase…

Continue Reading

MondayOct 07, 2019 11:58 am

NetworkNewsBreaks – Neutra Corp. (NTRR) Subsidiary Nearing Market Release of Hemp-Based Sports Cream Expected to be Hit with Amateur and Pro Athletes

Early-stage research and development company Neutra Corp. (OTCQB: NTRR) today announced that its subsidiary VIVIS Corp. is rapidly approaching the market release of a new transdermal, hemp-based sports cream. According to the update, the company believes the new product will prove popular with amateur athletes and others seeking relief after tough workouts and performances. The announcement is the latest in Neutra’s series of bold initiatives that it undertook earlier this year to grab a share of a market analysts predict will hit $11 billion by 2026. “We’re now seeing the positive payoff of hiring a dedicated sports medicine advisor earlier…

Continue Reading

MondayOct 07, 2019 11:13 am

NetworkNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Announces Launch of Edibles Products into Nevada Adult-Use Cannabis Market

Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF), a leading cannabis branded products company in the U.S., this morning announced the launch of its best-selling gummies* into the Nevada market. According to the update, the products are manufactured through the company’s partnership with TapRoot Holdings Inc., a vertically integrated cannabis company operating cultivation and manufacturing facilities in Las Vegas, Nevada. Commercialization comes just four months after PLUS and TapRoot’s entry into a definitive agreement. "Operating in Nevada only four months after signing a definitive agreement with TapRoot is a testament to our commitment to execution in building a national footprint," PLUS…

Continue Reading

MondayOct 07, 2019 10:37 am

NetworkNewsBreaks – Genprex, Inc.’s (NASDAQ: GNPX) Pioneering Use of Non-Viral Vector Delivery for Gene Therapy Validated by Additional Industry Research

Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) today announced additional research in the field validating non-viral vector delivery as the next evolution in gene therapy. Per the update, a recently published paper titled, “Encapsulation, Visualization and Expression of Genes with Biomimetically Mineralized Zeolitic Imidazolate Framework-8 (ZIF-8),” by researchers in Australia, Spain and Austria, supports the belief that non-viral delivery could be a safer alternative for patients than viral vectors, also potentially speeding production time while reducing costs. Genprex was not involved in the study that used a different nanotechnology. “One of the biggest differentiators between Genprex and other gene therapy…

Continue Reading

MondayOct 07, 2019 10:05 am

NetworkNewsBreaks – Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) Representative Assumes Board Positions with Organizations Fostering International Cannabis Industry Growth

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, today announced that a representative of the company has assumed board positions with three international organizations committed to promote and foster global cannabis industry growth. According to the update, Organigram’s Vice President of Public Affairs and Stakeholder Relations (North America), Cameron Bishop, has assumed board seats on The American Trade Association for Cannabis and Hemp, The Policy Center for Public Health & Safety (both U.S.-based) and the European Alliance for Medical Cannabis, as well as a board chair position on the…

Continue Reading

FridayOct 04, 2019 3:14 pm

NetworkNewsBreaks – VPR Brands LP (VPRB) Offers Robust Suite of Products in Nicotine, CBD Verticals

VPR Brands (OTCQB: VPRB) has developed of a suite of brands for the nicotine and CBD (cannabidiol) markets. An article discussing the results reads, “VPR Brands expects to launch a second CBD brand — Dr. Good Hemps — into the marketplace this year. The company is concentrating on cannabis consumables, focusing on leveraging the numerous opportunities available in this space. With major regulatory shifts toward the CBD vertical, the market is forecast to grow to an estimated $22 billion by 2022 (http://nnw.fm/aK65j). . . .  VPR Brands offers a compelling investment opportunity for investors looking for exposure to the nicotine and…

Continue Reading

FridayOct 04, 2019 3:08 pm

NetworkNewsBreaks – Independent Vaping Retailers & Manufacturers Urge Congress to Establish Significant Market Reform

Over 600 independently owned vaping retailers and manufacturers came together to release a white paper today formally responding to CDC claims about the link of e-cigarettes and recent illnesses and deaths. The white paper also outlined specific solutions for policy makers to address the youth epidemic including the limitation of flavors to lower nicotine products sold through adult-only retail establishments. It also suggested implementing an examination of nicotine strength and risk profiles as well as encouraging manufacturers to build age verification tools into all hardware. “Although state health departments and the FDA have continued to link recent respiratory illnesses with…

Continue Reading

FridayOct 04, 2019 2:16 pm

NetworkNewsBreaks – Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) Advancing Toward Production Capacity Increase

Organigram Holdings (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, is advancing on its goal to increase its licensed production capacity to 76,000 kilograms per year. An article discussing the company reads, “Additional construction outlined in phase 4B of the company’s expansion plans is on schedule to be completed later this month. The company plans on submitting the licensing amendment for its remaining 16 phase 4B cultivation rooms this month as well. The perimeter of phase 5 of the company’s expansion, which will include an edibles and derivative product facility and more…

Continue Reading

FridayOct 04, 2019 2:08 pm

NetworkNewsBreaks – Geyser Brands Inc. (TSX.V: GYSR) Adds All-Natural, Hemp-Based Pet Treats to Offerings

Geyser Brands (TSX.V: GYSR), a global science-led, consumer, health-care company, recently completed the acquisition of hemp-oil product manufacturer Solace Management. Among others, Solace’s brands and assets include the Apawthecary Pets line of products. An article discussing the company reads, “The company’s Apawthecary Pets line of products has established itself as a leading source for all-natural, hemp-based pet treats, with formulations for snacks, salves and oral drops. Animals, like humans, may suffer from the insomnia, digestive difficulties, pain and inflammation that hemp products are designed to relieve. All of Apothecary’s products are made with organic, cold-pressed and unrefined hemp-seed oil extract.…

Continue Reading